What's new

PSUSA/00002920/202408

PSUSA/00002920/202408

Apr 15, 2025 - 16:56
 0
PSUSA/00002920/202408
PSUSA/00002920/202408
Read More

Tags:

Previous Article

J&J keeps forecasts steady as pharma confronts tariff threat

Next Article

Driving bottom line margin growth through AI inventory management

Related Posts

Extensions of marketing authorisations: questions and answers

Extensions of marketing authorisations: questions and a...

Mar 25, 2025  0

Call for scientific data for the periodic review of the...

Apr 1, 2025  0

Human medicines European public assessment report (EPAR): Anoro Ellipta (previously Anoro), umeclidinium bromide,vilanterol, Date of authorisation: 08/05/2014, Revision: 21, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 27, 2025  0